BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16492799)

  • 1. Negative symptoms in schizophrenia: comments from a clinical psychology perspective.
    Tarrier N
    Schizophr Bull; 2006 Apr; 32(2):231-3. PubMed ID: 16492799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An industry perspective on the NIMH consensus statement on negative symptoms.
    Alphs L
    Schizophr Bull; 2006 Apr; 32(2):225-30. PubMed ID: 16469940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NIMH-MATRICS consensus statement on negative symptoms.
    Kirkpatrick B; Fenton WS; Carpenter WT; Marder SR
    Schizophr Bull; 2006 Apr; 32(2):214-9. PubMed ID: 16481659
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.
    Green MF; Nuechterlein KH; Kern RS; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Seidman LJ; Stover E; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):221-8. PubMed ID: 18172017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative symptoms of schizophrenia: a problem that will not go away.
    Stahl SM; Buckley PF
    Acta Psychiatr Scand; 2007 Jan; 115(1):4-11. PubMed ID: 17201860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into severe mental illness, hope, and quality of life of persons with schizophrenia and schizoaffective disorders.
    Hasson-Ohayon I; Kravetz S; Meir T; Rozencwaig S
    Psychiatry Res; 2009 May; 167(3):231-8. PubMed ID: 19394091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K; Kettler L; Galletly C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia.
    Aki H; Tomotake M; Kaneda Y; Iga J; Kinouchi S; Shibuya-Tayoshi S; Tayoshi SY; Motoki I; Moriguchi K; Sumitani S; Yamauchi K; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Res; 2008 Feb; 158(1):19-25. PubMed ID: 18160137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of schizophrenic disorders from the psychologist's viewpoint].
    Plaum E
    Nervenarzt; 1976 Mar; 47(3):145-52. PubMed ID: 1264298
    [No Abstract]   [Full Text] [Related]  

  • 10. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.
    Green MF
    J Clin Psychiatry; 2006 Oct; 67(10):e12. PubMed ID: 17107235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting quality of life in a multiracial sample of older persons with schizophrenia.
    Bankole AO; Cohen CI; Vahia I; Diwan S; Kehn M; Ramirez PM
    Am J Geriatr Psychiatry; 2007 Dec; 15(12):1015-23. PubMed ID: 18056820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of health-related quality of well-being in older patients with schizophrenia.
    Mittal D; Davis CE; Depp C; Pyne JM; Golshan S; Patterson TL; Jeste DV
    J Nerv Ment Dis; 2006 May; 194(5):335-40. PubMed ID: 16699382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: consensus statement on negative symptoms.
    Kane J
    Schizophr Bull; 2006 Apr; 32(2):223-4. PubMed ID: 16221996
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug initiatives to improve cognitive function.
    Marder SR
    J Clin Psychiatry; 2006; 67 Suppl 9():31-5; discussion 36-42. PubMed ID: 16965187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes toward medication in inpatients with schizophrenia: a cluster analytic approach.
    Santone G; Rucci P; Muratori ML; Monaci A; Ciarafoni C; Borsetti G
    Psychiatry Res; 2008 Apr; 158(3):324-34. PubMed ID: 18262656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of life and schizophrenia].
    Guelfi JD
    Soins Psychiatr; 1993; (154-155):50-4. PubMed ID: 8122161
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of life of patients with schizophrenia 2.
    Daradkeh TK; Al Habeeb T
    East Mediterr Health J; 2005; 11(5-6):898-904. PubMed ID: 16761659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.